Levosulpiride Eg (Levosulpiride)

Levosulpiride acts as a selective dopamine D2 receptor antagonist. In the brain, this reduces dopaminergic overactivity, alleviating psychotic symptoms. In the gut, D2 blockade enhances cholinergic activity, stimulating gastric emptying and providing prokinetic benefits.

The appropriate dose of levosulpiride is determined by the prescribing clinician based on the specific indication, patient characteristics, and therapeutic response. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for levosulpiride in pregnancy and lactation are limited. It is generally advised to avoid use unless the potential benefit justifies the potential risk to the fetus or infant, and decisions should be made in consultation with a healthcare professional.

To request Levosulpiride Eg, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Levosulpiride differs from many antipsychotics by combining dopamine D2 antagonism with prokinetic activity, making it useful for both psychiatric and gastrointestinal indications. Compared with typical antipsychotics, it may have a lower propensity for certain metabolic side effects but still carries risk of extrapyramidal symptoms.

Levosulpiride Eg should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability.

Levosulpiride Eg is administered orally, typically as a tablet taken with or without food as directed by the prescriber. The exact timing and frequency depend on the individual treatment plan established by the healthcare provider.

Serious risks include extrapyramidal symptoms such as tardive dyskinesia, neuroleptic malignant syndrome, severe hyperprolactinemia, and rare cardiac arrhythmias. Patients should be monitored for these events, and any concerning symptoms should prompt immediate medical evaluation.

Levosulpiride is contraindicated in patients with known hypersensitivity to the drug or other benzamide antipsychotics. Caution is advised for individuals with severe renal impairment, uncontrolled cardiac disease, or those taking medications that may cause dangerous interactions.